FIELD: medicine, clinical pharmacology. SUBSTANCE: invention relates to the method of pharmacological correction of disturbances in energetic metabolism in the brain. Bergenia crassifolia leaves extract is used as a cerebroprotecting agent in encephalopathy. An agent shows high specific activity and low adverse effects due to its low toxicity. EFFECT: enhanced effectiveness of an agent. 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
CEREBROPROTECTING AGENT SHOWING ANTIHYPOXIC AND ANTIRADICAL ACTIVITY | 1998 |
|
RU2141331C1 |
CEREBROPROTECTING AGENT AND METHOD OF ITS PREPARING | 2000 |
|
RU2180584C1 |
AN ANTIHYPOXIC AGENT | 1996 |
|
RU2121357C1 |
CARDIOPROTECTIVE, ANTIARRHYTHMIC ANTI-ISHEMIC AGENT | 2007 |
|
RU2366426C2 |
CEREBROPROTECTIVE AGENT | 2012 |
|
RU2501562C1 |
CEREBROPROTECTIVE AGENT | 2012 |
|
RU2497540C1 |
METHOD FOR CARRYING OUT EXPERIMENTAL ENCEPHALOPATHY THERAPY | 2004 |
|
RU2284060C1 |
TEA SPECIES OF HERBS | 1992 |
|
RU2045277C1 |
MEDICATION POSSESSING HAEMOSTIMULATING, ANTIMUTAGENIC, ANTITUMOUR, CEREBROPROTECTIVE, ANTIHYPOXIC, NOOTROPIC, ANXIOLYTIC AND ANTINEUROTIC ACTION | 2010 |
|
RU2438691C1 |
METHOD FOR CONTROLLING ERYTHROPOIESIS DISORDERS IN EXPERIMENTAL ENCEPHALOPATHY CASES | 2005 |
|
RU2302664C2 |
Authors
Dates
1999-11-20—Published
1998-06-17—Filed